Author name: Shamnad Basheer

Prof. (Dr.) Shamnad Basheer founded SpicyIP in 2005. He's also the Founder of IDIA, a project to train underprivileged students for admissions to the leading law schools. He served for two years as an expert on the IP global advisory council (GAC) of the World Economic Forum (WEF). In 2015, he received the Infosys Prize in Humanities in 2015 for his work on legal education and on democratising the discourse around intellectual property law and policy. The jury was headed by Nobel laureate, Prof. Amartya Sen. Professional History: After graduating from the NLS, Bangalore Prof. Basheer joined Anand and Anand, one of India’s leading IP firms. He went on to head their telecommunication and technology practice and was rated by the IFLR as a leading technology lawyer. He left for the University of Oxford to pursue post-graduate studies, completing the BCL, MPhil and DPhil as a Wellcome Trust scholar. His first academic appointment was at the George Washington University Law School, where he served as the Frank H Marks Visiting Associate Professor of IP Law. He then relocated to India in 2008 to take up the MHRD Chaired Professorship in IP Law at WB NUJS, a leading Indian law school. Later, he was the Honorary Research Chair of IP Law at Nirma University and also a visiting professor of law at the National Law School (NLS), Bangalore. Prof. Basheer has published widely and his articles have won awards, including those instituted by ATRIP, the Stanford Technology Law Review and CREATe. He was consulted widely by the government, industry, international organisations and civil society on a variety of IP issues. He also served on several government committees.

SpicyIP Jobs–patent posn in Infosys BPO, dubai teaching job and inhouse counsel at luxor

We would request that when you are writing to the concerned people (whose emails are shown below), please mention that you are coming via SpicyIP (as a favour to us–if you think this is a valuable service that we provide). At the very least, they will know that you are upto date on IP matters 🙂 It will only do you good…..Thanks very much in advance. 1. Senior Patent Attorney and Junior Patent Attorney Required at an Infosys BPO: Ritivik […]

SpicyIP Jobs–patent posn in Infosys BPO, dubai teaching job and inhouse counsel at luxor Read More »

Arogyapacha: A "Green" Approach to Pharmaceutical Innovation

Happy New Year to all of you. We thank you all for your readership and for the outstanding support in all our causes last year. There will be plenty more coming in this year! What better way to start the “new” year than by focusing on the “old”. In one of my earliest posts on the blog (in 2005, when sheer boredom prompted me to dabble with a blog) I had committed to bringing you an update on a famous

Arogyapacha: A "Green" Approach to Pharmaceutical Innovation Read More »

Petition to Increase Transparency at the Indian Patent Office

We wish to sincerely thank our readers and many others who supported us in our drive to increase transparency at the Indian Patent Office. Letters to the Prime Minister, Dr Manmohan Singh (and other Ministers and public functionaries involved with IP) were sent two weeks back, along with all your signatures. We were pleasantly surprised at receiving support/signatures from unexpected quarters–folks that were interacting regularly with the patent office and ran the risk of attracting their ire. We salute their

Petition to Increase Transparency at the Indian Patent Office Read More »

Moser Baer’s Pricing Strategy: The New Anti-Piracy Model?

Moser Baer, an Indian leader in digital media manufacture (DVD’s and VCD’s) is helping change the piracy paradigm. In a laudable initiative, they are acquiring copyright licenses to a wide range of movies and selling DVD’s/VCD’s for rock bottom prices. Needless to state, this move will reduce the scope for piracy considerably. Illustratively, a normal DVD version of a movie costs around Rs 200 (USD 5) or upwards in India, whereas the version sold by Moser Baer costs around Rs

Moser Baer’s Pricing Strategy: The New Anti-Piracy Model? Read More »

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS?

Rosica PR News reports that: “Secure Symbology, a New Jersey-based business that has successfully developed and implemented the only tested and proven anti-counterfeiting solution for pharmaceuticals, has been named “Emerging Business of the Year” by NJBiz. The counterfeiting of pharmaceutical drugs is a serious issue that poses a real threat to the unsuspecting public, and many consumers who rely on prescription medications have suffered catastrophic consequences to their health by consuming fake, or even toxic, prescriptions. Founded in 2003 and

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS? Read More »

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS?

Rosica PR News reports that: “Secure Symbology, a New Jersey-based business that has successfully developed and implemented the only tested and proven anti-counterfeiting solution for pharmaceuticals, has been named “Emerging Business of the Year” by NJBiz. The counterfeiting of pharmaceutical drugs is a serious issue that poses a real threat to the unsuspecting public, and many consumers who rely on prescription medications have suffered catastrophic consequences to their health by consuming fake, or even toxic, prescriptions. Founded in 2003 and

"TECHNOLOGY" SOLUTION FOR PARALLEL IMPORTS? Read More »

SpicyIP Jobs and Fellowships

1. Leading UK law firm seeks Patent Attorney in Singapore The successful candidate will be involved in a wide range of work and will also be involved in the strategic direction of the patent practice. This role requires drafting of patent specifications, advise on filing and protection strategies, patent audits and supervising the drafting work of a team of patent engineers. The ideal candidate should have a degree in the field of Electrical / Electronics Engineering with patent prosecution experience

SpicyIP Jobs and Fellowships Read More »

Novartis Patent Challenged in the US: More light…

Readers will recollect an earlier post dealing with a potential challenge to Novartis’ Glivec patent in the US. A patent expert who wishes to remain anonymous (we’ve labeled him “X” for the sake of brevity) throws more light on this case. We thank X for taking the time to share these extremely incisive comments. “The first P-IV ANDA was filed in March 2007. From the Livemint report, it appears that the FDA did not accept the ANDA (this could happen

Novartis Patent Challenged in the US: More light… Read More »

SpicyIP Petition: Indian Patent Database

Thanks to the overwhelming support of many of our readers , our online petition has now garnered close to 100 signatures. An interesting mix of folks who signed–ranging from students to attorneys/in-house counsels to academics/policymakers to even the founder of a company that first brought Ayurveda to the US. For those of you who support the cause and still haven’t signed, we would please request you to do so now. The petition is available here. We intend submitting this petition

SpicyIP Petition: Indian Patent Database Read More »

Novartis’ Gleevec Patent Challenged in the US?

With characteristic flair, CH Unnikrishnan of Livemint is again the first to unearth this interesting story: “US drugs regulator food and drug administration (FDA) has accepted a generic challenge by India’s Sun Pharmaceuticals Industries Ltd against Glivec, a controversial mega-earner cancer drug of Novartis AG, potentially weakening the Swiss drug maker’s petition against an Indian ruling denying the drug a patent. The challenge in the US, if it invalidates Novartis’ patent, will not only significantly stre-ngthen the plea of local

Novartis’ Gleevec Patent Challenged in the US? Read More »

Scroll to Top